Skip to main content
Lincoln Pharmaceuticals ltd. logo

Lincoln Pharmaceuticals ltd. — Investor Relations & Filings

Ticker · LINCOLN ISIN · INE405C01035 LEI · 3358004B6OBJNW8RTT10 BSE.NS Manufacturing
Open in API
Filings indexed 453 across all filing types
Latest filing 2020-03-31 Regulatory Filings
Country IN India
Listing BSE.NS LINCOLN

About Lincoln Pharmaceuticals ltd.

https://www.lincolnpharma.com/

Lincoln Pharmaceuticals Ltd. focuses on the development, manufacturing, and marketing of a diverse range of therapeutic formulations. The organization operates advanced manufacturing facilities certified by international standards, including WHO-GMP. Its portfolio spans multiple areas such as anti-infectives, cardiovascular, gastrointestinal, respiratory, and pain management. The company is recognized for its research and development initiatives, particularly in Novel Drug Delivery Systems (NDDS). Key offerings include specialized treatments for tinnitus and a wide array of formulations in dosage forms like tablets, capsules, liquid orals, and injectables. It maintains a significant global footprint, supplying products to numerous international markets across Africa, Southeast Asia, and Latin America, supported by a robust distribution network for its extensive healthcare catalog.

Recent filings

Filing Released Lang Actions
Trading Window
Regulatory Filings Classification · 95% confidence The document is a formal letter addressed to stock exchanges (BSE and NSE) regarding the closure of the trading window pursuant to SEBI regulations on insider trading. It specifies the trading window closure period from April 1, 2020, until 48 hours after the declaration of financial results for the quarter and year ended March 31, 2020. The document does not contain any financial data, results, or detailed report content. It is an announcement related to compliance and trading restrictions ahead of financial results disclosure. The document length is short (2195 characters), and it serves as a notification rather than a report or detailed filing. Therefore, it fits best under Regulatory Filings (RNS), which covers general regulatory announcements and compliance documents that do not fit other categories.
2020-03-31 English
Disclosure under SEBI Takeover Regulations
Regulatory Filings
2020-03-16 English
Disclosure under SEBI Takeover Regulations
Regulatory Filings
2020-03-05 English
Appointment
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is dated February 27, 2020, and is addressed to the National Stock Exchange of India Limited and BSE Limited, indicating it is a regulatory filing related to the Indian stock exchanges. The subject line mentions 'Outcome of the Meeting,' which typically refers to the announcement of results from a shareholder or board meeting. The document includes signatures from the Managing Director and an annexure with particulars and details, but no substantive financial data or detailed report content is present. The document length is 4275 characters, which is relatively short and consistent with an announcement rather than a full report. There is no indication of detailed financial statements, audit opinions, or management discussion. Therefore, this document is best classified as a Declaration of Voting Results & Voting Rights Announcement (DVA), as it reports the outcome of a meeting, likely shareholder voting results or resolutions passed.
2020-02-27 English
Resignation
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is titled 'Outcome of the Meeting' dated February 27, 2020, and references stock exchanges (BSE and NSE) and a scrip code. It includes a signature from the Managing Director and an annexure with details. The content indicates it is reporting the results or outcomes of a shareholder or board meeting rather than the meeting materials themselves. The document length is 4477 characters, which is relatively short and consistent with a voting or meeting outcome announcement. There is no detailed financial data or comprehensive report content, so it is not an Annual Report (10-K) or Interim Report (IR). The document is not a proxy solicitation or presentation. The best fit is Declaration of Voting Results & Voting Rights Announcements (DVA), as it reports the outcome of a meeting, likely an AGM or EGM, including resolutions passed or voting results.
2020-02-27 English
Date of payment of dividend
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is dated February 27, 2020, and is addressed to the National Stock Exchange of India Limited and BSE Limited, indicating it is a regulatory filing related to the Indian stock exchanges. The subject line mentions 'Outcome of the Meeting,' which typically refers to the announcement of results from a shareholder or board meeting. The document contains no detailed financial data or comprehensive report content but rather a summary or outcome statement. The length is 4268 characters, which is relatively short and consistent with an announcement rather than a full report. There is no indication of detailed financial statements, audit opinions, or management discussions. Therefore, this document is best classified as a Declaration of Voting Results & Voting Rights Announcements (DVA), as it reports the outcome of a meeting, likely shareholder voting results or resolutions passed.
2020-02-27 English

Browse filings by year

11 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.